14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $11.01 $14.21 Friday, 3rd May 2024 IOVA stock ended at $13.63. This is 5.82% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.36% from a day low at $13.30 to a day high of $13.88.
90 days $7.62 $18.33
52 weeks $3.21 $18.33

Historical Iovance Biotherapeutics, Inc. prices

Date Open High Low Close Volume
Sep 28, 2023 $4.48 $4.57 $4.36 $4.56 4 033 081
Sep 27, 2023 $4.48 $4.57 $4.38 $4.50 4 678 597
Sep 26, 2023 $4.64 $4.84 $4.41 $4.44 5 466 424
Sep 25, 2023 $4.83 $4.84 $4.51 $4.57 10 702 755
Sep 22, 2023 $5.05 $5.17 $4.81 $4.87 6 997 598
Sep 21, 2023 $5.18 $5.20 $4.98 $5.04 5 015 489
Sep 20, 2023 $5.48 $5.71 $5.24 $5.25 5 623 131
Sep 19, 2023 $5.90 $5.99 $5.42 $5.43 8 866 567
Sep 18, 2023 $5.58 $6.18 $5.43 $5.93 22 622 158
Sep 15, 2023 $5.75 $5.97 $5.13 $5.27 52 830 265
Sep 14, 2023 $5.48 $5.48 $4.41 $4.65 19 964 362
Sep 13, 2023 $5.94 $5.97 $5.36 $5.44 5 951 694
Sep 12, 2023 $6.03 $6.47 $5.94 $5.96 3 494 690
Sep 11, 2023 $5.98 $6.12 $5.90 $6.03 2 398 944
Sep 08, 2023 $5.80 $6.10 $5.77 $5.95 2 897 532
Sep 07, 2023 $5.90 $5.95 $5.76 $5.80 3 329 042
Sep 06, 2023 $6.04 $6.09 $5.81 $5.99 3 236 055
Sep 05, 2023 $6.07 $6.24 $6.02 $6.04 2 919 703
Sep 01, 2023 $6.07 $6.19 $5.98 $6.15 2 801 433
Aug 31, 2023 $6.16 $6.24 $6.03 $6.04 3 670 715
Aug 30, 2023 $6.09 $6.19 $6.05 $6.16 2 480 173
Aug 29, 2023 $6.10 $6.27 $6.06 $6.12 1 676 973
Aug 28, 2023 $6.20 $6.29 $6.01 $6.12 1 896 590
Aug 25, 2023 $6.10 $6.24 $5.98 $6.15 2 952 760
Aug 24, 2023 $6.31 $6.32 $6.06 $6.08 3 307 989
Click to get the best stock tips daily for free!

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics. Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers... IOVA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT